 |
Over-the-Counter Products for Oral Ulcerations
Over-the-counter products can be useful for alleviating pain from ulcerations of the oral mucosa.
By William M. Carpenter, DDS, MS, and Sol Silverman Jr., MA, DDS
 |
Over-the-counter products can be useful and effective in alleviating
the pain from ulcerations of the oral mucosa. This article reviews over-the-counter
medications that are available to treat ulcerative lesions. Among the categories
included are covering agents, local anesthetics, and mouthrinses.
|
Article copyright 1998 Journal of the California Dental Association.
Photographs copyright of the authors.
Ulcerations of the oral mucosa are a frequent occurrence as a result
of many etiologic factors. An ulcer (loss of the surface epithelium) may
be of a primary type (no previous lesion) or secondary to a previous lesion
(vesicle or bulla).1 The differential diagnosis would include those conditions
shown in Table 1. This discussion will not involve recurrent herpes
labialis (cold sores).
|
Table 1
|
Traumatic events
Physical
Thermal
Chemical |
Vesicular disease
Microbiologic (usually viral) |
Immunologic
Recurrent aphthae
Bullous disease |
| Hypersensitivity reactions |
| Leukopenic ulcers secondary to:
Immunosuppression
Drug-induced toxicities
|
| Radiation-induced ulcers |
Microbiologic
Fungal
Baterial |
Neoplastic
Benign
Malignant |
|
Since so many different pathologic conditions may present in an ulcerative
state and require different therapeutic/management approaches, the most
important first step for treatment is an accurate diagnosis. This is often
a very difficult task, and many diagnostic studies may be required.2
Once a working or definitive diagnosis is established, there are many effective
and specific prescription medications or treatments that may be indicated.
However, a number of ulcerative lesions require only a period of time until
the epithelium can regenerate. See Table 1.1-4
During this time, over-the-counter products may be useful and effective
in alleviating the pain involved regardless of the etiologic agent. The
advantages of an OTC product are the cost, availability and lack of side
effects. The main side effect, if the instructions are properly followed,
would be a hypersensitivity to one of the ingredients.
OTC Products(3-6)
Localized Use (Direct Application)
Covering Agents
Several products are available that are covering agents (emollients).
They act to ameliorate the pain by forming a protective covering.
The two main products in this category are:
- Orabase (Colgate Oral Pharmaceutics) -- an emollient paste composed
of sodium carboxymethyl cellulose with pectin, gelatin, sugar gum, cellulose
gum and tragacanth gum dispersed in a plasticized hydrocarbon gel composed
of 5 percent polyethylene in mineral oil.
- Zilactin (Zila Pharmaceuticals) -- a film-forming liquid composed
of a hydroxypropyl cellulose and 10 percent benzyl alcohol.
These two products have been utilized for many years, and both are effective.
However, some personal preferences exist, both with patients and practitioners.
Both products have optionally available an anesthetic, benzocaine, to provide
additional relief, if pain is severe.
Local Anesthetics
- Orabase - B -- Benzocaine 20 percent.
- Zilactin - B -- Benzocaine 10 percent.
In addition, another product is available.
- Orabase - B Gel -- Benzocaine 15 percent w/w as the active ingredient
in ethylcellulose with ethyl alcohol, 57 percent w/w propylene glycol,
salicylic acid, tannic acid and sodium saccharin.
Other commercially available products containing benzocaine as the active
ingredient are:
- Anbesol Liquid (maximum strength) -- Benzocaine 20 percent, alcohol
60 percent and saccharin (maximum strength).
- Anbesol Liquid -- Benzocaine 6.4 percent w/v, phenol 0.5 percent,
potassium iodide, alcohol 70 percent v/v povidone iodine, camphor, glycerin
and menthol.
- Anbesol Gel (Whitehall Labs) -- Benzocaine 6.4 percent and 0.5
percent phenol, carbomer 934P.
- Senso-gard (Block Drug Co.) -- Benzocaine 20 percent, methylparaben,
polycarbophil, polyethylene glycol, propylparaben and sorbitan mono-oleate.
- Tanac (Del Pharmaceuticals) -- Benzocaine 10 percent and benzalkonium
chloride 0.12 percent, polyethylene glycol 400, water, sodium saccharin,
propylene glycol and tannic acid.
- Orajel Mouth-Aid (Del Pharmaceuticals) -- Benzocaine 20 percent,
benzalkonium chloride 0.02 percent, zinc chloride 0.1 percent, allantoin,
carbomer, edentate disodium, peppermint oil, polysorbate 1.0, saccharin,
sorbic acid, polyethylene and propylene glycol, propyl gallate, water,
povidone, and stearyl alcohol.
- Kank-A (Blistex Inc.) -- Benzocaine 20 percent, cetylpyridium
chloride 0.5 percent, mgm, 1 gm benzyl alcohol with benzoin tincture, castor
oil, dimethyl isosorbide, saccharin, ethylcellulose, tannic acid and propylene
glycol.
- Medadyne (Dal-Med Pharmaceuticals ) -- Benzocaine and methylbenzethonium
chloride, methol camphor, benzyl alcohol, chlorothymol in a hydro-alcoholic
base 61 percent.
- Hurricaine Liquid and Gel (Beutlich Pharmaceuticals) -- Benzocaine
20 percent, polyethylene glycol flavoring.
One other product that has been in use for a long time, principally for
sore throats but also for relief of pain in mouth sores, is a phenol product.
- Vicks Chloraseptic sore throat spray (Procter & Gamble) --
Active: phenol 1.4 percent; inactive: D&C green No. 5, D&C yellow
No. 10, FD&C green No. 3, flavor, glycerin, purified water, saccharin
sodium.
Oxygenating Agents
Hydrogen peroxide is a major ingredient in several products as a mouthrinse
or for direct application. The oxygenating effect helps to debride the
ulcer and is a mild antibacterial
agent.
- Peroxyl Mouthrinse (Colgate Oral Pharmaceuticals) -- 1.5 percent
hydrogen peroxide in an aqueous solution with ethyl alcohol 6 percent v/v
sorbitol solution 70 percent, polysorbate 20 methyl salicylate, menthol,
pluronic F108 and sodium saccharin.
- Peroxyl Oral Spot Treatment Gel (Colgate Oral Pharmaceuticals)
-- 1.5 percent hydrogen peroxide in a gel base.
Other oxygenating products are available that contain carbamide peroxide
as the active ingredient:
- Cankaid Rinse (Dickinson Co.) -- Carbamide peroxide 10 percent
in anhydrous glycerol, citric acid monohydrate, sodium citrate dihydrate,
and edentate (disodium).
- Gly-Oxide (Smith-Kline Beecham) -- Carbamide peroxide 10 percent,
citric acid, glycerin, propylene glycol, sodium stannate and water.
- Periolav (Spectrumed, Inc.) -- Carbamide peroxide 10 percent in
anhydrous glycerol.
- Orajel Perioseptic spot treatment (Del Pharmaceuticals) -- Carbamide
peroxide 15 percent in anhydrous glycerin, citric acid, edentate disodium,
methylparaben, propylene glycol, water, sodium chloride, sodium saccharin.
Cauteries and Antiseptics
Other products are available that are chemical cauteries and mild antiseptics.
Examples of this type of product are:
- Ora - 5 (Premier Dental Products Co.) -- Copper sulfate, iodine,
potassium, iodide and alcohol 1.5 percent.
- Oralief (H.T.C. Co.) -- Zinc chloride, phenol, cetylpyridium chloride,
alcohol, and glycerin.
Mouthrinses
There are several ulcerative conditions that are multifocal and/or
diffuse and require a topical medication in a more easily applied form
than direct application. These are available in liquid form and act as
a covering agent. They can be swished and expectorated.
One combination is available as separate medications over the counter and
can be mixed by the patient:
- Diphenhydramine hydrochloride (Benadryl) syrup (4 ounce). Mix
equal parts Kaopectate liquid (12 ounce) or Maalox suspension (12 ounce).
Sig: Rinse for one minute with 1 teaspoonful and expectorate. Repeat every
two hours or at mealtimes.
If more of an anesthetic effect is desired, Hurricaine liquid may be added.
(When topical anesthetics are used, patients should be cautioned concerning
a reduced gag reflex and the need to avoid aspiration.)
- Biotene Mouthwash (Laclede Products) -- Lysozyme (40 mg) lactoferrin
(15mg) glucose oxidase 2,500 units, lactoperoxidase 2,500 units, calcium
lactate, sodium benzoate, benzoic acid, propylene glycol, hydroxyethol
cellulose, aloe vera, peppermint, water, xylitol hydrogenated starch.
- Orajel Perioseptic (Del Pharmaceuticals) -- Hydrogen peroxide
1.5 percent, edentate disodium ethyl alcohol (4 percent v/v), methyl salicylate
methylparaben, phosphoric acid, poloxamer 338, water, sodium saccharin
and sorbitol.
- Amosan (Oral-B Labs Inc.) -- Sodium peroxyborate monohydrate buffered
with sodium bitartrate.
Summary
These OTC medications have been employed successfully for many years
in alleviating the pain associated with oral lesions and are major agents
in the arsenal of the practitioner. The lack of prospective controlled
studies make outcome assessments difficult, and none of these has been
shown conclusively to be other than palliative. Therefore preferences and
benefits are variable in a population. Furthermore, it must be understood
that an ulcer may be the manifestation of a serious disease that requires
a more definitive treatment. Therefore, if lesions do not show any evidence
of healing in a matter of a week, a definitive diagnosis must be ascertained
and a more specific treatment rendered.
Authors
William M. Carpenter, DDS, MS, is in the Department of Pathology and
Medicine, University of the Pacific School of Dentistry.
Sol Silverman Jr., MA, DDS, is in the Department of Stomatology at the
University of California at San Francisco School of Dentistry.
References
1. Regezi JA and Sciubba J, Oral Pathology, Clinical Pathologic Correlations,
2nd ed. WB Saunders Co, Philadelphia, 1993.
2. Eversole LR, Oral Pathology, Clinical Outline of Diagnosis and Treatment,
3rd ed. Lea and Febinger, Philadelphia, London, 1992.
3. Physicians Desk Reference for Nonprescription Drugs. Medical Economics
Co Inc, Montvale, NJ, 1997.
4. The Blue Book. American Academy of Oral Pharmacology, 24200 Chagrin
Blvd, Cleveland, OH 44122, pp 15-8.
5. Dental Therapeutic Digest. Odontos Publishing Inc, 34696 Vine
St, Eastlake, OH 44095, 1997.
6. Clinicians Guide to Treatment of Common Oral Conditions. American
Academy of Oral Medicine, 159 W 53rd St, New York, NY 10019.
To request a printed copy of this article, please contact/William M. Carpenter,
DDS, MS, UOP School of Dentistry, Department of Pathology and Medicine,
Room 400, San Francisco, CA 94115.
|